There is evidence to indicate that full adrenergic blockade by carvedilol improves survival and cardiovascular outcome in patients with heart failure compared with metoprolol treatment ...

Metoprolol is a beta-blocker approved by the Food and Drug Administration (FDA) to treat several cardiovascular conditions, ...

Metoprolol is a beta-blocker that affects the heart and circulation (blood flow through arteries and veins). Metoprolol is used to treat angina (chest pain) and hypertension (high blood pressure).

A pharmacist explains the similarities and differences between these two heart medications Atenolol (brand name Tenormin) and ...

Apo-Si is a platform technology for the delivery of genetic drugs, such as siRNA, into cells. The Apo-Si construct (Fig. 1b) comprises MNMs conjugated to a siRNA cargo drug, and it has two major ...

Metoprolol succinate 25mg, 50mg, 100mg, 200mg; scored ext-rel tabs. Toprol-XL Tablets are supplied in 100- and 1000-count bottles in the following strengths: 25 mg: white, biconvex, film-coated ...

Metoprolol succinate 25mg, 50mg, 100mg, 200mg; ext-rel caps. Metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent. This preferential effect is not absolute ...

Maack et al. [70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class.

No significant news for APO in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...